iShares Biotechnology ETF $IBB Shares Sold by Tudor Financial Inc.

Tudor Financial Inc. trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 38.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,487 shares of the financial services provider’s stock after selling 4,670 shares during the period. Tudor Financial Inc.’s holdings in iShares Biotechnology ETF were worth $1,424,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Citigroup Inc. raised its position in shares of iShares Biotechnology ETF by 40.9% in the fourth quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock valued at $884,808,000 after buying an additional 1,521,992 shares during the last quarter. Raymond James Financial Inc. grew its stake in iShares Biotechnology ETF by 286.2% in the 4th quarter. Raymond James Financial Inc. now owns 994,311 shares of the financial services provider’s stock worth $167,810,000 after acquiring an additional 736,881 shares during the period. Bank of America Corp DE grew its stake in iShares Biotechnology ETF by 10.8% in the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock worth $1,225,767,000 after acquiring an additional 707,343 shares during the period. LPL Financial LLC grew its stake in iShares Biotechnology ETF by 145.9% in the 4th quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock worth $167,555,000 after acquiring an additional 589,033 shares during the period. Finally, Janney Montgomery Scott LLC raised its holdings in iShares Biotechnology ETF by 1,871.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 619,550 shares of the financial services provider’s stock valued at $104,562,000 after acquiring an additional 588,124 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.0%

iShares Biotechnology ETF stock opened at $213.81 on Friday. The stock has a fifty day moving average price of $197.56 and a 200 day moving average price of $180.03. iShares Biotechnology ETF has a 52 week low of $138.79 and a 52 week high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.